DexCom (DXCM) PT Raised to $170 at Stephens
Stephens analyst Chris Cooley raised the price target on DexCom (NASDAQ: DXCM) to $170.00 (from $160.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
